Research Excellence Award
Murimisi Mukansi
University of The Witwatersrand, South Africa
Murimisi Mukansi is a researcher at the University of The Witwatersrand whose academic interests encompass cardiovascular medicine, infectious diseases, pulmonary disorders, and biomarker-based clinical investigations. His published work demonstrates an evidence-based approach to understanding disease mechanisms and improving patient management through translational medical research. With an established Scopus profile, consistent citation record, and growing international visibility, his contributions support advances in cardiovascular science and clinical medicine while promoting interdisciplinary collaboration between laboratory investigation and patient-centered healthcare.[1]
Abstract
The research activities of Murimisi Mukansi focus on cardiovascular complications associated with infectious diseases, particularly pneumonia and COVID-19. His investigations evaluate clinical manifestations, cardiac biomarker responses, and disease severity to strengthen diagnostic accuracy and improve patient outcomes. The published findings contribute to evidence-based cardiovascular medicine and interdisciplinary clinical research.[2]
Keywords
Cardiovascular Medicine, COVID-19, Community-Acquired Pneumonia, Cardiac Biomarkers, Clinical Research, Translational Medicine, Infectious Diseases, Medical Diagnostics.
Introduction
Modern cardiovascular medicine increasingly recognizes the influence of infectious diseases on cardiac health. Investigating biomarker profiles, inflammatory responses, and clinical outcomes provides valuable evidence for optimizing diagnosis and treatment. Research in this area supports improved management of patients presenting with complex cardiopulmonary conditions.[2]
Research Profile
Murimisi Mukansi has established an academic profile through publications in peer-reviewed medical journals, supported by 170 citations and an h-index of 5. His work demonstrates expertise in cardiovascular investigations, infectious disease pathology, biomarker evaluation, and collaborative clinical research that addresses contemporary healthcare challenges.[1]
Research Contributions
His recent publication examining clinical characteristics and cardiac biomarker elevation among patients with community-acquired pneumonia and COVID-19 pneumonia provides comparative evidence supporting cardiovascular risk assessment in infectious diseases. Such studies contribute to improved clinical interpretation, patient stratification, and therapeutic decision-making.[2]
Publications
- Distinct Patterns of Clinical Features and Cardiac Biomarker Elevation in Community-Acquired Pneumonia and COVID-19 Pneumonia. Pathogens, 2026.
Research Impact
The research contributes to a broader understanding of cardiovascular complications associated with respiratory infections. By integrating biomarker analysis with clinical observations, the findings support precision medicine, improved patient monitoring, and evidence-informed healthcare strategies for complex infectious diseases.[2]
Award Suitability
Murimisi Mukansi demonstrates qualities consistent with recognition through the International Research Awards on Cardiology & Cardiovascular Medicine. His scholarly contributions, publication quality, interdisciplinary collaborations, and focus on clinically relevant cardiovascular research illustrate scientific excellence and meaningful impact within contemporary medical research.
Conclusion
Murimisi Mukansi has developed a research portfolio centered on cardiovascular complications arising from infectious diseases. His work strengthens understanding of disease mechanisms, supports improved diagnostic practice, and contributes valuable evidence for clinicians and researchers seeking to enhance patient care through translational cardiovascular science.
External Links
References
- Elsevier. (n.d.). Scopus author details: Murimisi Mukansi, Author ID 56659430900. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56659430900
- Mukansi, M., Steel, H. C., Rossouw, T. M., et al. (2026). Distinct Patterns of Clinical Features and Cardiac Biomarker Elevation in Community-Acquired Pneumonia and COVID-19 Pneumonia. Pathogens.
DOI: https://doi.org/10.3390/pathogens15070676